Eleva Secures up to EUR 60 million to Advance a Drug Candidate...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
FREIBURG, Germany, January 6, 2021, /PRNewswire-AsiaNet/-- Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from v...
Authors: LATEST ASIANET NEWS RELEASES
